Synthesis and initial in vitro evaluation of olmutinib derivatives as prospective imaging probe for non-small cell lung cancer

Muammar Fawwaz ^1,2 * , Kenji Mishiro ³ * , Arwansyah Arwansyah ⁴, Ryuichi Nishii ⁵, Kazuma Ogawa ^2,3 *

Cited by CrossRef: 3

1- Arsul M, Fawwaz M, Fawwaz H, Multazam M, Trihadi Kusuma A, Nisa K, Pratama M, Bangar R, Hafiz I, Iriani R, Iriani A, Purwono B. Metabolomic profiling of Boehmeria virgata leaves and antioxidant, α-glucosidase inhibitory, and cytotoxic activities targeting EGFR L858R/T790M . Natural Product Research. 2026;:1 [Crossref]

2- Fawwaz M, Yusri I, Pratama M, Azizah R, Gozal R, Asnida A, Purwono B, Sidiq Y, Sidiq A, Sidiq H, Arsul M, Idrus H, Olii A. Molecular Insight, Antioxidant, and Cytotoxicity Evaluation of Vitex trifolia Leaves Against EGFR L858R/T790M and Wild Type in Lung Carcinoma. ChemistrySelect. 2025;10(38) [Crossref]

3- Taiyeb M, Hartati H, Arwansyah A, Arwansyah D, Muis A, Mu'nisa A, Arif A, Salleh L. Self-Nanoemulsifying Drug Delivery System (SNEDDS) formulation and molecular docking of mahogany seed extract (Swietenia mahagoni) as anti-hyperglycemic. Informatics in Medicine Unlocked. 2024;47:101517 [Crossref]

4- Buronov A, Gaybullaev S, Murtazaeva Z, Ruzieva F, Khushnazarov Z, Turgunov D, Nasrullaev A, Kuryazov R, Takhirov Y, Tursunov F, Kushatov T, Dushamov D, Matmuratov S, Nurullaeva N, Shodikulova A, Khalikov K, Kholmurodova D, Numonov S, Niu C, Ji Y, Zhao J, Ge Z, Bozorov K. Thieno[3,2-d]pyrimidines in Anticancer Drug Discovery: Recent Advances in Drug Design and Molecular Targets. Int J Mol Sci. 2026;27(16):7457 [Crossref]

5- Fawwaz M, Purwono B, Sidiq Y, Sidiq A, Arsul M, Arsul F, Pratama M, Fajriani A, Kusuma A, Kusuma A, Musdalifah A, Sarfandi A, Baits M. Anti‐inflammatory, Antioxidant, and Antibacterial Activities with Molecular Docking Studies of Vitex Trifolia L. Targeting Human COX‐2 and Peroxiredoxin‐5. ChemistrySelect. 2024;9(39) [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Indexing and Abstracting Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2025): 19%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of
Follower of ICMJE
Permission: CC BY-NC